Medicare Enrolled

Dr. David Tellalian, MD

Infectious Disease · Los Angeles, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
8635 W 3RD ST STE 465W, Los Angeles, CA 90048
3103582300
In practice since 2008 (17 years)
NPI: 1003073826 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tellalian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tellalian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Tellalian

Dr. David Tellalian is an infectious disease specialist in Los Angeles, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Tellalian performed 833 Medicare services across 550 unique beneficiaries.

Between the years covered by Open Payments, Dr. Tellalian received a total of $9,855 from 20 pharmaceutical and/or device companies across 512 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Tellalian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 43% volume in CA $9,855 industry payments

Medicare Practice Summary

Medicare Utilization ↗
833
Medicare services
Top 43% in CA for infectious disease
550
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~49 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
155 $67 $241
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
95 $8 $18
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
63 $10 $125
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
62 $102 $359
HIV-1 viral load test
A blood test that measures the amount of HIV-1 virus in your body using nucleic acid detection.
58 $83 $300
Chlamydia trachomatis nucleic acid amplification test
A laboratory test that uses nucleic acid amplification to detect the presence of Chlamydia trachomatis bacteria in a sample.
54 $34 $100
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
54 $66 $145
Gonorrhea nucleic acid amplification test
A laboratory test that uses amplified probe techniques to detect the genetic material of gonorrhea bacteria. This method identifies the presence of the infection by analyzing nucleic acids from the sample.
53 $34 $100
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
37 $45 $125
Lipid panel (cholesterol and triglycerides)
A blood test that measures cholesterol and triglyceride levels.
28 $13 $65
Total estradiol level test
A blood test that measures the total amount of estradiol, a form of estrogen, in the body.
25 $27 $50
Total testosterone level test
A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women.
25 $25 $85
Free thyroxine (T4) test
A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream.
24 $9 $35
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
21 $10 $40
Follicle stimulating hormone (FSH) level
A blood test to measure the level of follicle stimulating hormone, a reproductive hormone.
18 $18 $40
Luteinizing hormone level test
A blood test that measures the level of luteinizing hormone, a reproductive hormone. This test helps evaluate hormonal balance and reproductive function.
18 $18 $40
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
17 $8 $50
Hepatitis C antibody test
A blood test that checks for antibodies to the hepatitis C virus. This test helps determine if a person has been exposed to the virus.
15 $14 $40
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
11 $140 $300
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,855
Total received (2018-2024)
Avg $1,408/year across 7 years
Top 16% in CA for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
20
Companies
512
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,685 (98.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$170 (1.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,658
2023
$2,335
2022
$1,792
2021
$1,394
2020
$384
2019
$941
2018
$1,350

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ViiV Healthcare Company
$973
Gilead Sciences, Inc.
$345
ABBVIE INC.
$152
Lilly USA, LLC
$47
Amgen Inc.
$41
Napo Pharmaceuticals Inc
$28
Theratechnologies Inc.
$26
Merck Sharp & Dohme LLC
$25
EMD Serono, Inc.
$22
Top 3 companies account for 88.6% of 2024 payments
All-time payments by company (2018-2024) ›
ViiV Healthcare Company
$5,183
Gilead Sciences, Inc.
$2,150
Janssen Biotech, Inc.
$676
Theratechnologies Inc.
$213
Merck Sharp & Dohme Corporation
$208
EMD Serono, Inc.
$176
Napo Pharmaceuticals Inc
$171
ABBVIE INC.
$152
Novo Nordisk Inc
$143
Merck Sharp & Dohme LLC
$136
Antares Pharma, Inc.
$123
Amgen Inc.
$108
INSYS Therapeutics Inc
$82
Janssen Products, LP
$70
Dynavax Technologies Corporation
$64
Astellas Pharma US Inc
$61
IDORSIA PHARMACEUTICALS US INC
$60
Lilly USA, LLC
$47
Janssen Scientific Affairs, LLC
$16
Endo Pharmaceuticals Inc.
$16
Top 3 companies account for 81.3% of all-time payments
Associated products mentioned in payments ›
APRETUDE · AVEED · Biktarvy · CABENUVA · COMPLERA · CRESEMBA · DELSTRIGO · DOVATO · Descovy · EGRIFTA · EGRIFTA SV · GARDASIL 9 · Heplisav-B · ISENTRESS · JULUCA · MAVYRET · Mytesi · NOCDURNA · Otezla · PIFELTRO · PREZCOBIX · PREZISTA · QUVIVIQ · RUKOBIA · SEROSTIM · SYMTUZA · SYNDROS · Saxenda · Serostim · Symtuza · TRIUMEQ · TROGARZO · Wegovy · XYOSTED · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an infectious disease specialist in Los Angeles?
Compare infectious diseases in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse infectious diseases nearby

Geographic Context

Infectious diseases within 10 mi
271
Per 100K population
2.8
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Tellalian is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 16% of CA peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Tellalian experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Tellalian performed 155 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tellalian receive payments from pharmaceutical companies?
Yes. Dr. Tellalian received a total of $9,855 from 20 companies across 512 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tellalian's costs compare to other infectious diseases in Los Angeles?
Dr. Tellalian's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tellalian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →